I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)
This is a randomized, double-blind study of rilzabrutinib in participants with persistent or chronic ITP, with an average platelet count of <30,000/μL (and no single platelet count >35,000
neutrophil count
kidney function tests
thrombocytopenia
platelet count
igiv
- 0 views
- 03 Dec, 2024
- 48 locations